ペプチド及びその使用
PROBLEM TO BE SOLVED: To provide a peptide capable of activating antigen-specific CD8-positive T cells derived from a pathogenic microorganism.SOLUTION: According to the present invention, there are provided: a peptide consisting of 9-50 amino acids that comprises amino acids 61-70 in the amino acid sequence of Ag85B protein of Mycobacterium kansasii; a peptide consisting of an amino acid sequence in which one or several amino acids is deleted, substituted or added in the peptide and is capable of activating pluripotent CD8 positive T cells; and an acid-fast bacterial peptide vaccine composition comprising a peptide capable of activating CD4 positive T cells against an acid-fast bacterium.SELECTED DRAWING: None.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 26. Feb. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2021-02-26, Last updated: 2021-03-11 |
|---|
| Patentnummer: |
JP6828871 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004370147 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004370147 | ||
| 003 | DE-627 | ||
| 005 | 20230503172032.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2021 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)EPA004370147 | ||
| 035 | |a (EPA)JP6828871 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 245 | 1 | 0 | |a ペプチド及びその使用 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2021-02-26, Last updated: 2021-03-11 | ||
| 520 | |a PROBLEM TO BE SOLVED: To provide a peptide capable of activating antigen-specific CD8-positive T cells derived from a pathogenic microorganism.SOLUTION: According to the present invention, there are provided: a peptide consisting of 9-50 amino acids that comprises amino acids 61-70 in the amino acid sequence of Ag85B protein of Mycobacterium kansasii; a peptide consisting of an amino acid sequence in which one or several amino acids is deleted, substituted or added in the peptide and is capable of activating pluripotent CD8 positive T cells; and an acid-fast bacterial peptide vaccine composition comprising a peptide capable of activating CD4 positive T cells against an acid-fast bacterium.SELECTED DRAWING: None | ||
| 650 | 4 | |a C07K | |
| 650 | 4 | |a A61K | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61P | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 26. Feb. |
| 773 | 1 | 8 | |g year:2021 |g day:26 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/searchResults?DB=EPODOC&locale=en_EP&query=JP6828871B2 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 26 |c 02 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 26 |c 02 | ||